BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1669691)

  • 1. Progress toward the isolation and characterization of the genes causing neurofibromatosis.
    Menon AG; Gusella JF; Seizinger BR
    Brain Pathol; 1990 Sep; 1(1):33-40. PubMed ID: 1669691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards the isolation and characterization of the genes causing neurofibromatosis.
    Menon AG; Gusella JF; Seizinger BR
    Cancer Surv; 1990; 9(4):689-702. PubMed ID: 2129297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the breakpoint of a constitutional translocation on chromosome 22 in a patient with NF2.
    Arai E; Tokino T; Imai T; Inazawa J; Ikeuchi T; Tonomura A; Nakamura Y
    Genes Chromosomes Cancer; 1993 Apr; 6(4):235-8. PubMed ID: 7685627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical mapping of a translocation breakpoint in neurofibromatosis.
    Fountain JW; Wallace MR; Bruce MA; Seizinger BR; Menon AG; Gusella JF; Michels VV; Schmidt MA; Dewald GW; Collins FS
    Science; 1989 Jun; 244(4908):1085-7. PubMed ID: 2543076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
    Narod SA; Parry DM; Parboosingh J; Lenoir GM; Ruttledge M; Fischer G; Eldridge R; Martuza RL; Frontali M; Haines J
    Am J Hum Genet; 1992 Sep; 51(3):486-96. PubMed ID: 1496982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NF1 translocation breakpoint region.
    O'Connell P; Cawthon RM; Viskochil D; White R; Carey JC; Buchberg AM
    Ann N Y Acad Sci; 1991; 615():319-31. PubMed ID: 1903909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
    Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
    Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.
    Yagle MK; Parruti G; Xu W; Ponder BA; Solomon E
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7255-9. PubMed ID: 2119504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1).
    Seizinger BR; Farmer GE; Haines JL; Ozelius LJ; Anderson K; Korf BR; Parry DM; Pericak-Vance MA; Mulvihill JJ; Menon A
    Am J Hum Genet; 1989 Jan; 44(1):30-2. PubMed ID: 2491778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type I.
    O'Connell P; Leach RJ; Ledbetter DH; Cawthon RM; Culver M; Eldridge JR; Frej AK; Holm TR; Wolff E; Thayer MJ
    Am J Hum Genet; 1989 Jan; 44(1):51-7. PubMed ID: 2562822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of neurofibromatosis-associated tumours.
    Lin AL; Gutmann DH
    Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards identifying the neurofibromatosis (NF1) gene.
    Collins FS; O'Connell P; Ponder BA; Seizinger BR
    Trends Genet; 1989 Jul; 5(7):217-21. PubMed ID: 2506682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of NF1-related loci on human chromosomes 22, 14 and 2.
    Hulsebos TJ; Bijleveld EH; Riegman PH; Smink LJ; Dunham I
    Hum Genet; 1996 Jul; 98(1):7-11. PubMed ID: 8682511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17.
    Fountain JW; Wallace MR; Brereton AM; O'Connell P; White RL; Rich DC; Ledbetter DH; Leach RJ; Fournier RE; Menon AG
    Am J Hum Genet; 1989 Jan; 44(1):58-67. PubMed ID: 2491783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the translocation breakpoint on chromosome 22q12.2 in a patient with neurofibromatosis type 2 (NF2).
    Arai E; Ikeuchi T; Nakamura Y
    Hum Mol Genet; 1994 Jun; 3(6):937-9. PubMed ID: 7951241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage analysis of von Recklinghausen neurofibromatosis to DNA markers on chromosome 17.
    Diehl SR; Boehnke M; Erickson RP; Baxter AB; Bruce MA; Lieberman JL; Platt DJ; Ploughman LM; Seiler KA; Sweet AM
    Genomics; 1987 Dec; 1(4):361-3. PubMed ID: 2896631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations.
    O'Connell P; Viskochil D; Buchberg AM; Fountain J; Cawthon RM; Culver M; Stevens J; Rich DC; Ledbetter DH; Wallace M
    Genomics; 1990 Aug; 7(4):547-54. PubMed ID: 2117565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting.
    Bull World Health Organ; 1992; 70(2):173-82. PubMed ID: 1600579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.